Funding Rounds
Nanolive

Nanolive Series C (2022, $2M)

Nanolive

Platform for observing live cells in 3D without damaging them.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $2.20M

Raised Date: 2022-01-01